“We believe that was very carefully selected, we believe that there’s very high probability of delivering a solution to an unmet need not because the current vaccines are not effective, but they are don’t have the safety profile that we hope we can achieve with this technology.” – Pfizer CEO Albert Bourla
That sure sounds to me as if the company CEO is concerned that mRNA vaccine technology doesn’t measure up to whatever safety profile the company utilizes. A safety profile from a company with legal immunity so how low is that bar? Pro-vax Pfizer lovers will spin this as a good thing. The company is concerned about safety even when they have legal immunity. Maybe you’ll convince me when Pfizer pulls its vaccines off the shelves voluntarily and immediately due to safety concerns.
Let’s remember the bottom line. The vaccine manufacturers must get their vaccines added to the childhood schedule. That’s on top of the 16 current vaccines adding up to 72 shots by the time a child reaches age 18 if they take them all. Only then will they maintain legal immunity from safety issues once the Emergency Use Authorization expires. That’s guaranteed income without legal concerns. The Pfizer CEO isn’t going to pull his product and likely shut the door on mRNA vaccine technology because there is far, far more at stake in the future than just a single vaccine.
Spellchek 